Why Glioblastoma Can Return After Treatment @uctv
Why Glioblastoma Can Return After Treatment  @uctv
Uploaded November 2026 | Updated November 2026, 4 days ago
A version of this video with audio description track is available here:
youtube.com/watch?v=PdU_4UR8UQs

Why does glioblastoma often return after treatment? Joe Costello, Ph.D., of UC San Francisco, examines two connected processes underlying this aggressive brain cancer: tumor evolution and the ability of cancer cells to keep dividing. Using three-dimensional sampling across multiple regions of brain tumors, his research investigates small populations of early ancestral cells that appear to survive treatment and may contribute to recurrence. Costello also examines how changes involving the TERT gene help tumor cells maintain their ability to divide. In laboratory and animal experiments, his team tests ways to interfere with proteins that activate TERT, while using artificial intelligence to identify additional potential targets. Although much of this research remains preliminary, it offers new insights into why glioblastoma is difficult to treat and possible directions for future therapies. [Show ID: 40859]

0:00 Glioblastoma Evolution and Whole-Tumor Sampling
3:50 What Whole-Tumor Genetic Mapping Reveals
14:01 Early Cancer Cells and Tumor Recurrence
19:49 How Glioblastoma Changes After Treatment
31:11 How Cancer Cells Keep Dividing
37:26 Targeting TERT and Testing Protein Degraders
43:03 Using AI to Identify Potential Cancer Targets
47:54 Questions About Resistant Cells and Drug Delivery

Donate to UCTV to support informative & inspiring programming:
uctv.tv/donate

Please Note: Knowledge about health and medicine is constantly evolving. This information may become out of date.

More videos from: Sanford Stem Cell Institute Seminar Series
(uctv.tv/stem-cell/stem-cell-seminar/)

More from: Stem Cell Channel
(uctv.tv/stem-cell)

Explore More Health & Medicine on UCTV
(uctv.tv/health)
UCTV features the latest in health and medicine from University of California medical schools. Find the information you need on cancer, transplantation, obesity, disease and much more.

Explore More Science & Technology on UCTV
(uctv.tv/science)
Science and technology continue to change our lives. University of California scientists are tackling the important questions like climate change, evolution, oceanography, neuroscience and the potential of stem cells.

UCTV is the broadcast and online media platform of the University of California, featuring programming from its ten campuses, three national labs and affiliated research institutions. UCTV explores a broad spectrum of subjects for a general audience, including science, health and medicine, public affairs, humanities, arts and music, business, education, and agriculture. Launched in January 2000, UCTV embraces the core missions of the University of California -- teaching, research, and public service – by providing quality, in-depth television far beyond the campus borders to inquisitive viewers around the world.
(https://www.uctv.tv)

FAQ

Q: Why does glioblastoma often return after treatment?

A: Glioblastoma contains genetically different populations of cancer cells, some of which may survive surgery, chemotherapy, and radiation. Costello's research has identified small populations of early ancestral cells that appear to persist through treatment and may give rise to new tumor growth. These preliminary findings could help explain why recurrent tumors sometimes differ significantly from the original tumor.

Q: What is cancer cell immortality, and how does TERT contribute to it?

A: Most healthy cells can divide only a limited number of times because their telomeres, protective structures at the ends of chromosomes, gradually shorten. Many cancer cells overcome this limit by activating TERT, a gene involved in maintaining telomeres. Mutations that increase TERT activity can help cancer cells continue dividing.

Q: Can researchers target cancer cell immortality to treat glioblastoma?

A: Researchers are investigating ways to interfere with proteins that activate TERT in cancer cells. Experimental work targeting the GABP protein complex has reduced TERT expression in cancer cell lines and improved survival in animal studies. These findings are preliminary and require further research before they can be considered treatments for patients.
Why Glioblastoma Can Return After TreatmentMedicaid: What is itCARTA: Genetic History of Humans and Animals in South Asia with Maanasa RaghavanNew Insights into Placental BiologyBack to Our Roots: What Grandma Didn’t Tell You About Chinese HerbsMaternal & Infant HealthWalking the Pier: Women in Scripps Plankton ResearchCARTA: The Genetic History of Europe with Johannes KrauseFunding Enables Life-Changing ProstheticsWhy Topology Matters for Data Science and AIHealth in Adolescent GirlsLearning Beyond the Data: Adam Klivans on Distribution Shift and the Future of AI
University of California Television (UCTV) |

Why Glioblastoma Can Return After Treatment

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER